We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
신규 편입 · 포트폴리오 비중 0.02%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $47 · 8 analysts
Stored first · Google News · Yahoo Finance (English)
Needham Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $45 - Moomoo
Needham Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $45 Moomoo
Is AtriCure's (ATRC) Russell 2000 Defensive Debut Quietly Reframing Its Risk‑Reward Profile? - simplywall.st
Is AtriCure's (ATRC) Russell 2000 Defensive Debut Quietly Reframing Its Risk‑Reward Profile? simplywall.st
Is AtriCure (ATRC) Still Undervalued Following Its Russell Defensive Index Additions? - simplywall.st
Is AtriCure (ATRC) Still Undervalued Following Its Russell Defensive Index Additions? simplywall.st
Stocks With Rising Relative Strength: AtriCure - MSN
Stocks With Rising Relative Strength: AtriCure MSN
Form 4 AtriCure Inc For: 2 July By Investing.com - Investing.com Canada
Form 4 AtriCure Inc For: 2 July By Investing.com Investing.com Canada
AtriCure (ATRC) CEO adds 636 shares through 2018 Employee Stock Purchase Plan - Stock Titan
AtriCure (ATRC) CEO adds 636 shares through 2018 Employee Stock Purchase Plan Stock Titan
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 28. | After market close (AMC) | $0.02 | — | — | $151.84M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.14 | — | — | $123.62M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.62 | — | — | $341.03M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.45 | — | — | $225.12M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 07. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 02. 19. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 02. 19. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2026. 02. 18. | Citizens | — | Maintain | Market Outperform → Market Outperform | — | Citizens: Market Outperform |
| 2026. 02. 18. | Oppenheimer | — | Downgrade | Outperform → Perform | — | Oppenheimer: Outperform → Perform |
| 2026. 02. 18. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 751,003 | $21.43M | 0.02% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 380,499 | $15.05M | 0.02% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 277,924 | $10.99M | 0.02% | — | New position |